Skip to main content
. 2025 Jan 7;31(1):101463. doi: 10.3748/wjg.v31.i1.101463

Table 5.

Adverse events in each group, n (%)

Symptom
First-line, n = 250
Rescue, n = 130
Total, n = 380
Nonadherence due to AE
Failed in treatment
Skin rash 5 (2.0) 3 (2.3) 8 (2.1) 3 1
Abdominal pain 5 (2.0) 2 (1.5) 7 (1.8) 1 1
Abdominal discomfort 3 (1.2) 4 (3.1) 7 (1.8) 1 0
Diarrhea 4 (1.6) 1 (0.8) 5 (1.3) 0 0
Vomiting 3 (1.2) 0 3 (0.8) 0 0
Increased bowl movement 1 (0.4) 1 (0.8) 2 (0.5) 0 0
Abdominal distension 2 (0.8) 0 2 (0.5) 0 0
Constipation 1 (0.4) 1 (0.8) 2 (0.5) 0 0
Heartburn 1 (0.4) 0 1 (0.3) 0 0
Itchy skin 1 (0.4) 0 1 (0.3) 0 0
Nausea 1 (0.4) 0 1 (0.3) 0 0
Fever 1 (0.4) 0 1 (0.3) 0 0
Headache 0 1 (0.8) 1 (0.3) 0 0
Dizziness 1 (0.4) 0 1 (0.3) 0 0
Blood pressure decrease 1 (0.4) 0 1 (0.3) 0 0
Total AE 23 (9.2) 13 (10.0) 36 (9.5) 5 2
Adherence 247 (98.8) 128 (98.5) 375 (98.7)

AE: Adverse event.